Full corporate governance report 2011 - Straumann

More documents

Recommendations

Info

operational review corporate governance 109 ANDY MOLNAR British (born 1962), Executive Vice President North America Thomas Dressendörfer Andy Molnar has a proven track record in the dental and healthcare industries having held senior managerial roles in global business sales and country management. Under his leadership as General Manager of Straumann UK from 2006–2009, the company rose to national market leadership in implant dentistry. In 2009, Mr Molnar moved to Group headquarters as Senior Vice President Global Regenerative Sales and Member of the Corporate Management Group. In this position, he successfully orchestrated and supervised key product launches, in addition to driving significant growth in global sales of oral tissue regeneration products. He joined Straumann in 2005 from SIDHIL, a UK medical equipment company, where he was Sales and Marketing Director. However, the bulk of his career – eleven years – was spent in sales and management roles at GlaxoSmithKline Pharmaceuticals. Andy Molnar holds a Bachelor of Science degree from Reading University, in Physiology and Biochemistry, and an MBA from Bradford University. He was appointed to his current position at the beginning of 2012. Frank Hemm responsible for biomaterials product management and development from 1997 to 2002. He was also a co-founder of Kuros Therapeutics. Dr Matter is a member of the Industrial Advisory Board (IAB) for the Department of Mechanical & Process Engineering (DMAVT) of the ETH Zurich. He joined Straumann in 2002 as Head of the Biologics and Research Division and headed the Products Division from 2005 through 2011. He was appointed to his current position at the beginning of 2012. Dr René WILLI Swiss (born 1967), Executive Vice President Business Unit Surgical René Willi acquired much of his professional experience working in and for the medical device industry. His career began in engineering and sales – at EMS Inventa and then VonRoll Innova – and included international assignments in China and Europe. He then spent two and a half years at McKinsey&Company as a management consultant focusing on international mandates in the pharmaceutical and medical-device industries. In 2003, he moved to Medtronic to take on responsibilities in International Product Management and Marketing in the Cardiovascular Sector.
110 operational review corporate governance He joined Straumann in 2005 as Head of the Surgical Business Unit. From 2008 to 2010, he also headed Straumann's Regenerative Franchise and was a member of the Corporate Management Group. Dr Willi holds a Master’s degree in Chemical Engineering, a PhD in Technical Sciences and a postgraduate degree in Industrial Engineering and Management, all completed at the Swiss Federal Institute of Technology in Zurich. He is also an alumnus of the Medtronic Marketing Leader Pro- gram at the Wharton School (University of Pennsylvania). Dr Willi was appointed to his current position at the beginning of 2012. CORPORATE MANAGEMENT GROUP 2011 The EMB is supported by the Corporate Management Group (CMG), which serves as a discussion, sounding and alignment board for the EMB. On 31 December 2011, the CMG comprised 17 members: the Sales Heads of: Central Europe, Western Europe, Iberia, Nordics, Benelux, APAC, Japan, China, CARES Digital Solutions, and Regenerative; the Heads of: Global Marketing, Business Unit Surgical, Projects & Portfolio Planning, Global Operations, Corporate Human Resources, Corporate Business Development & Licensing, and the General Counsel. Changes in 2012 As part of the company’s reorganization, the CMG was redefined at the beginning of 2012 and expanded slightly to 21 members including: the Sales Heads of Central Europe, Western Europe, Iberia, Japan, China and North America; the Heads of Global Distributor Sales, Regenerative, Clinic Prosthetics, Lab Prosthetics, and Intra-Oral Scanners; the Market Managers of Surgical and Prosthetics, the Heads of Communication & Marketing Services, Project & Portfolio Planning, Product Management Surgical, Global Operations, Corporate Human Resources, Corporate Business Development & Licensing, Corporate Accounting, Planning & Reporting, and the General Counsel. Almost all of the new positions in the CMG were filled through internal promotions. The appointment and term of office of CMG members is decided by the EMB. SUPERVISORY/CONSULTING/POLITICAL FUNCTIONS Beat Spalinger is a Member of the Board of Directors and Board of Trustees of the independent academic network International Team for Implantology (ITI). Straumann supports the ITI with payments under a collaboration agreement (see Note 28 of the Audited Consolidated Financial Statements on p. 199 for details of payments in 2011). Sandro Matter is a member of the Industrial Advisory Board for the Department of Mechanical & Process Engineering of the ETH Zurich. Apart from these two cases, none of the Executive Management Board: • Performed any activities in governing or supervisory bodies of significant foreign or domestic organizations, institutions or foundations under private or public law • Held any permanent management or consultancy function for significant domestic or foreign interest groups • Held any official function or political post. MANAGEMENT CONTRACTS The Board of Directors and the Executive Management Board run the business directly. They have not delegated any managerial powers to persons or companies outside Straumann. INTERNAL MANAGEMENT DEVELOPMENT Straumann continued the Strategic Management Development System (SMD) program initiated in 2008 to assess, develop and deploy key people. The Group’s goal is to fill at least 50% of key management positions with internal candidates. With the exception of the CFO and the vacant position of Head of Sales Asia/Pacific, all of the Executive Management positions have been filled with internal candidates. For further information on the Company’s SMD program, see p. 66.
Page 1 and 2: corporate governance CONTENTS Princ
Page 3 and 4: 90 operational review corporate gov
Page 13 and 14: 100 operational review corporate go
Page 21: 108 operational review corporate go
Page 27: Tooth replacement Snakes (Serpentes
Page 30: Straumann Holding AG Peter Merian-W

Full corporate governance report 2011 - Straumann

Create successful ePaper yourself

Delete template?

Save as template?